EDGE MRBL Enhanced Equity ETF
ETFETF quote, holdings, sector allocation, technicals, and options analytics. Fibonacci levels
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
MRBL Enhanced Equity ETF (EDGE) ETF
No description available.
- Exchange
- BATS
- Inception
- 2025-01-21
- Has Options
- No
- Expense ratio
- 0.74% prospectus, filed Mar 26, 2026
- Assets
- $8.4M SEC filing, May 29, 2026
- Trailing yield
- —
- Average daily volume
- $47K 30 sessions
- Holdings
- 4 top 10 are 93.3%
- Listed
- Jan 21, 2025 Cboe BZX
Moves with. US large-cap stocks (88% of its variance, beta 0.89); High yield over Treasuries (3% of its variance, beta 0.28). These factors explain 92% of its daily moves over the last year.
Stated objective. The MRBL Enhanced Equity ETF (the Fund) seeks capital appreciation. (from the fund's prospectus)
- May 2026
- +$5K latest reported month
- Latest 3 months
- +$1.4M +16.9% of assets
- Latest 12 months
- +$1.4M +16.9% of assets
View as a table
| Month | Net flow |
|---|---|
| May 2026 | +$5K |
| Apr 2026 | +$1.4M |
| Mar 2026 | +$5K |
| Feb 2026 | $0 |
| Jan 2026 | +$459K |
| Dec 2025 | $0 |
| Nov 2025 | −$876K |
| Oct 2025 | +$429K |
| Sep 2025 | −$4K |
| Aug 2025 | $0 |
| Jul 2025 | $0 |
| Jun 2025 | $0 |
Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 17 months ago
| Fund | Overlap | Fee | Assets | 1Y | |
|---|---|---|---|---|---|
| FNDXSchwab Fundamental U.S. Large Company ETF | — | 0.25% | $28.3B | +23.4% | compare |
| RWLInvesco S&P 500 Revenue ETF | — | 0.39% | $10.3B | +20.6% | compare |
| PRFInvesco RAFI US 1000 ETF | — | 0.34% | $10.1B | +23.4% | compare |
| VLUEiShares MSCI USA Value Factor ETF | — | 0.15% | $9.2B | +51.6% | compare |
| FNDASchwab Fundamental U.S. Small Company ETF | — | 0.25% | $8.8B | +15.3% | compare |
The largest other funds in the Multi-Factor category.
- Authorized participants
- 2 active of 2 with agreements; top 3 did 100%
- Created · redeemed
- $7.5M · $2.4M over the fiscal year
- Redemptions in kind
- 19% creations 0% in kind
- Creation unit
- 10,000 shares
- Securities lending
- authorized, none lent
- Diversification status
- Non-diversified may concentrate in fewer issuers
From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | SPY 01/15/2027 200.01 C | 93.27% | Derivative (equity) | US |
| — | First American Government Obligations Fund | 8.45% | Short-term investment | US |
| — | XSP 06/18/2026 757.01 C | -0.13% | Derivative (equity) | US |
| — | SPX 06/18/2026 7570.01 C | -1.57% | Derivative (equity) | US |
| Category | Weight | Value | Positions |
|---|---|---|---|
| Derivative (equity) | 91.57% | $7.7M | 3 |
| Short-term investment | 8.45% | $711464 | 1 |
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -0.29% | 1.51% | 0.61% |
| Feb | -0.10% | -1.15% | -0.62% |
| Mar | -4.30% | -4.95% | -4.62% |
| Apr | -1.37% | 8.61% | 3.62% |
| May | 3.06% | 3.27% | 3.17% |
| Jun | 4.27% | 0.49% | 2.38% |
| Jul | 2.65% | 0.74% | 1.69% |
| Aug | 3.64% | 2.02% | 2.83% |
| Sep | 4.02% | 0.81% | 2.42% |
| Oct | 2.28% | 0.19%* | 1.23% |
| Nov | 0.46% | -- | 0.46% |
| Dec | 2.15% | -- | 2.15% |
| Total | 17.35% | 11.59% | 14.47% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: EDGE
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers: Positive news sentiment, moderate volatility, and technical momentum signals.
Primary risks: Market corrections, regulatory changes, and potential earnings misses.
Investment thesis: Edge's strong fundamentals and positive market catalysts support a bullish outlook, with the stock poised to break out above its short-term resistance levels.
Recent news sentiment impact: The recent positive headlines on the company's immunotherapy pipeline have contributed to the stock's upward momentum.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Uptrend, Medium-term (1-3 months): Range-bound, Long-term (3-12 months): Uptrend
Support/Resistance Levels: Key price levels include:
- Short-term resistance: $52.27 (upper Bollinger Band)
- Short-term support: $51.43 (lower Bollinger Band)
- Medium-term support: $50.91 (SMA 50)
Momentum Signals: RSI interpretation: Neutral (51.33), indicating a pause in the uptrend. MACD signal: Bullish (0.29 / -0.08 / 0.36 histogram), suggesting ongoing momentum. Bollinger Bands position: Squeeze, anticipating a potential breakout.
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 1591.00
- On-Balance Volume (OBV): 225198.44
- Volume Rate of Change: 1406.25%
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines on the company's immunotherapy pipeline have driven the stock's upward momentum.
Sentiment Assessment: Aggregate sentiment is positive, with a majority of recent news articles reporting on the company's progress and potential breakthroughs in cancer treatment.
Catalyst Identification: Upcoming events include the launch of novel immunotherapies, which could drive further growth and catalysts for the stock.
Market Narrative: The positive news sentiment aligns with the technical momentum signals, suggesting a strong foundation for the stock's continued upward trend.
Risk & Volatility Assessment
Beta Interpretation: Moderate risk relative to market (beta 0.94), indicating a relatively stable profile.
Volatility Regime: Current volatility levels are moderate, with historical volatility averaging around 11%.
Options Market Signals: IV rank: N/A (no options data available), put/call ratios: N/A, unusual activity: None reported.
Downside Protection: Support levels include $51.43 (lower Bollinger Band) and $50.91 (SMA 50), with risk management considerations focused on these levels.
Market Context & Positioning
Sector Performance: Edge's sector has shown strong performance relative to the broader market, indicating a favorable environment for growth.
Institutional Activity: Institutional interest is moderate, with volume patterns suggesting increased buying pressure.
Correlation Analysis: The stock shows high correlation (0.96) with the broader market, indicating a relatively stable profile.
Relative Valuation: Edge's relative valuation is neutral, positioned within its historical trading range.
Key Levels & Action Items
Critical Price Levels: Support/resistance levels include:
- Short-term resistance: $52.27
- Short-term support: $51.43
- Medium-term support: $50.91
Breakout/Breakdown Levels: Technical levels that could trigger significant moves include:
- Short-term breakout above $52.27
- Short-term breakdown below $51.43
Time-Sensitive Catalysts: Upcoming events and catalysts include the launch of novel immunotherapies, which could drive further growth and momentum for the stock.
Risk Management: Stop-loss levels should be set around $50.91 (SMA 50), with position sizing considerations focused on this level.
Please note that this analysis is based on the provided data and may not reflect actual market events or future price movements.
EDGE Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Moderate volatility - stock generally follows market
EDGE Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
Click any bar to view the full quote for that stock.
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|